[Form 4] BTCS Inc. Insider Trading Activity

Rhea-AI Filing Summary

Michael E. Prevoznik Jr., identified as the Chief Financial Officer of BTCS Inc. (BTCS), was granted 81,613 stock options on 08/07/2025 with an exercise price of $4.20 per share. The filing classifies these as derivative securities and reports 81,613 underlying common shares as beneficially owned following the grant. The options vest on December 31, 2026, subject to continued employment on that date, and the document lists 08/07/2032 in the date column associated with the award. The Form 4 was signed and dated 08/08/2025.

Insights

Corporate Governance Expert

TL;DR: Routine compensatory option grant to the CFO; vesting is employment-contingent and the grant is disclosed as direct ownership.

The Form 4 documents a standard executive equity award: 81,613 options at an exercise price of $4.20 granted on 08/07/2025. Vesting is explicitly tied to continued employment through 12/31/2026, which aligns executive pay with tenure. The filing lists the position (CFO) and reports direct beneficial ownership following the grant. This disclosure follows Section 16 reporting norms and provides transparency on potential dilution and insider alignment.

Compensation Analyst

TL;DR: The grant is a time‑based option award with a multi‑year vest and a stated exercise price, consistent with standard incentive design.

The awarded instrument is a stock option (derivative) for 81,613 shares at $4.20 per share, dated 08/07/2025. The explicit vesting date of 12/31/2026 conditions payout on continued employment. An expiration/associated date of 08/07/2032 is listed in the filing. As reported, ownership after the transaction equals the number of underlying shares, indicating this is a newly granted compensatory instrument rather than a disposition.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Prevoznik Michael Edward JR

(Last) (First) (Middle)

9466 GEORGIA AVENUE #124

(Street)

SILVER SPRING MD 20910

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BTCS Inc. [ BTCS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

3. Date of Earliest Transaction (Month/Day/Year)
08/07/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	$4.2	08/07/2025		A		81,613		(1)	08/07/2032	Common Stock	81,613	$0	81,613	D

Explanation of Responses:

1. The stock options vest on December 31, 2026, subject to continued employment with the Company on the vesting date.

	/s/ Michael E. Prevoznik JR	08/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did BTCS (BTCS) report by the CFO on 08/07/2025?

The Form 4 reports a grant of 81,613 stock options to CFO Michael E. Prevoznik Jr. on 08/07/2025.

What is the exercise price and vesting schedule for the BTCS option grant?

The options carry an exercise price of $4.20 and vest on December 31, 2026 subject to continued employment.

How many shares does the BTCS option grant cover and how are they reported?

The grant covers 81,613 underlying common shares, reported as directly beneficially owned following the transaction.

Does the Form 4 show an expiration or related date for the BTCS options?

The filing lists 08/07/2032 in the date column associated with the award; the form also includes the vesting date of 12/31/2026.

When was the Form 4 signed and filed for the BTCS transaction?

The Form 4 bears the reporting person's signature and date of 08/08/2025.